EW in the 13F filings
Edwards Lifesciences Corp · CUSIP 28176E108
- Quarter end
- 30 Sep 2024
- the date the book describes
- Filed
- 14 Nov 2024
- latest of these filings; the earliest 5 Nov 2024
- Managers listing it
- 19
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q2 2024 and Q3 2024; 10 listed it in both
- Shares listed
- 57,007,849
- combined, among listed positions
- Reported value
- $3.8bn
- combined, at the quarter end
Among the 94 comparable managers: 11 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing EW in Q3 2024
19 of 19 holders
Largest increases and reductions, by shares
Increases
- Wellington Management Group LLPexisting position · 31,532,725 shares now+14,610,123
- Voloridge Investment Management LLCnew position · 1,655,910 shares now+1,655,910
- Renaissance Technologies LLCnew position · 1,221,700 shares now+1,221,700
- Soros Fund Management LLCnew position · 300,000 shares now+300,000
- Quantbot Technologies LPnew position · 206,625 shares now+206,625
Reductions
- AllianceBernstein LPexisting position · 6,983,259 shares now-13,357,889
- Janus Henderson Group Ltdexisting position · 1,265,378 shares now-4,168,179
- T. Rowe Price Associates Incexisting position · 3,541,783 shares now-3,793,955
- Man Group PLCexisting position · 442,922 shares now-409,188
- Bridgewater Associates LPexisting position · 165,451 shares now-354,361
New positions and exits
New (6)
Exited (1)
- Artisan Partners LPwas $157m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 6 | $2.5bn | n.a. | n.a. |
| Q3 2013 | 14 | $2.3bn | n.a. | n.a. |
| Q4 2013 | 8 | $2.4bn | n.a. | n.a. |
| Q1 2014 | 10 | $2.9bn | n.a. | n.a. |
| Q2 2014 | 7 | $3.0bn | n.a. | n.a. |
| Q3 2014 | 13 | $2.9bn | n.a. | n.a. |
| Q4 2014 | 18 | $3.4bn | n.a. | n.a. |
| Q1 2015 | 18 | $3.1bn | n.a. | n.a. |
| Q2 2015 | 15 | $2.3bn | n.a. | n.a. |
| Q3 2015 | 16 | $2.8bn | n.a. | n.a. |
| Q4 2015 | 19 | $2.7bn | n.a. | n.a. |
| Q1 2016 | 20 | $2.7bn | n.a. | n.a. |
| Q2 2016 | 26 | $3.1bn | n.a. | n.a. |
| Q3 2016 | 21 | $3.8bn | n.a. | n.a. |
| Q4 2016 | 18 | $2.8bn | n.a. | n.a. |
| Q1 2017 | 23 | $2.0bn | n.a. | n.a. |
| Q2 2017 | 21 | $2.8bn | n.a. | n.a. |
| Q3 2017 | 24 | $2.7bn | n.a. | n.a. |
| Q4 2017 | 25 | $2.8bn | n.a. | n.a. |
| Q1 2018 | 23 | $3.7bn | n.a. | n.a. |
| Q2 2018 | 23 | $4.1bn | n.a. | n.a. |
| Q3 2018 | 17 | $5.2bn | n.a. | n.a. |
| Q4 2018 | 21 | $5.0bn | n.a. | n.a. |
| Q1 2019 | 23 | $6.1bn | n.a. | n.a. |
| Q2 2019 | 23 | $5.7bn | n.a. | n.a. |
| Q3 2019 | 24 | $6.7bn | n.a. | n.a. |
| Q4 2019 | 28 | $7.2bn | n.a. | n.a. |
| Q1 2020 | 29 | $5.8bn | n.a. | n.a. |
| Q2 2020 | 30 | $5.9bn | n.a. | n.a. |
| Q3 2020 | 21 | $6.1bn | n.a. | n.a. |
| Q4 2020 | 14 | $6.3bn | n.a. | n.a. |
| Q1 2021 | 22 | $6.0bn | n.a. | n.a. |
| Q2 2021 | 25 | $7.7bn | n.a. | n.a. |
| Q3 2021 | 22 | $8.5bn | n.a. | n.a. |
| Q4 2021 | 20 | $9.2bn | n.a. | n.a. |
| Q1 2022 | 22 | $7.9bn | n.a. | n.a. |
| Q2 2022 | 22 | $6.6bn | n.a. | n.a. |
| Q3 2022 | 29 | $6.2bn | n.a. | n.a. |
| Q4 2022 | 28 | $5.8bn | n.a. | n.a. |
| Q1 2023 | 26 | $5.8bn | n.a. | n.a. |
| Q2 2023 | 25 | $5.9bn | n.a. | n.a. |
| Q3 2023 | 25 | $4.6bn | n.a. | n.a. |
| Q4 2023 | 22 | $5.1bn | 10 | 12 |
| Q1 2024 | 23 | $7.0bn | 14 | 13 |
| Q2 2024 | 20 | $6.8bn | 12 | 11 |
| Q3 2024 | 19 | $3.8bn | 11 | 9 |
| Q4 2024 | 22 | $5.0bn | 12 | 11 |
| Q1 2025 | 23 | $5.0bn | 14 | 11 |
| Q2 2025 | 23 | $5.2bn | 17 | 7 |
| Q3 2025 | 22 | $5.0bn | 9 | 15 |
| Q4 2025 | 23 | $5.9bn | 22 | 14 |
| Q1 2026 | 25 | $6.0bn | 15 | 21 |
| Q2 2026 | 25 | $6.9bn | 18 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
EW and LLY →EW and JNJ →EW and VRTX →Choose a stock to compare with EW →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own EW, latest filings →Back to the 13F Explorer →